M
Marco Valgimigli
Researcher at University of Bern
Publications - 772
Citations - 91095
Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risks.
Antonio Landi,Mattia Branca,Pascal Vranckx,Sergio Leonardi,Enrico Frigoli,Dik Heg,Paolo Calabrò,B. Esposito,Gennaro Sardella,Carlo Tumscitz,Stefano Garducci,Giuseppe Andò,Ugo Limbruno,Paolo Sganzerla,Andrea Santarelli,Carlo Briguori,José M. de la Torre Hernández,Giovanni Pedrazzini,Stephan Windecker,Marco Valgimigli +19 more
TL;DR: In this paper , the comparative effectiveness of transradial (TRA) compared with transfemoral (TFA) access in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.
Journal ArticleDOI
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
Ply Chichareon,Ply Chichareon,David van Klaveren,David van Klaveren,Rodrigo Modolo,Rodrigo Modolo,Norihiro Kogame,Kuniaki Takahashi,Chun-Chin Chang,Mariusz Tomaniak,Mariusz Tomaniak,Jinqing Yuan,Lihua Xie,Ying Song,Shubin Qiao,Yuejin Yang,Changdong Guan,Aleksander Zurakowski,Robert-Jan van Geuns,Manel Sabaté,Paul Jau Lueng Ong,Joanna J. Wykrzykowska,Jan J. Piek,Scot Garg,Christian W. Hamm,Gabriel Steg,Gabriel Steg,Pascal Vranckx,Marco Valgimigli,Stephan Windecker,Peter Jüni,Yoshinobu Onuma,Ewout W. Steyerberg,Bo Xu,Patrick W. Serruys,Patrick W. Serruys +35 more
TL;DR: In this article, the logistic clinical SYNTAX score was updated after imputing missing values by refitting the original model (refitted original model) and fitting an extended new model (new model, with, selection based on the Akaike Information Criterion) external validation was performed in 10,100 patients having PCI at Fu Wai hospital Chronic obstructive pulmonary disease, prior stroke, current smoker, hemoglobin level, and white blood cell count were included into the new model.
Journal ArticleDOI
Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviews.
TL;DR: The authors are frankly disappointed by the recent article appraising the risk of death in patients randomized to sirolimus-eluting (Cypher) vs. bare-metal stents, which amounts to a missed opportunity.
Journal ArticleDOI
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update
TL;DR: This study highlights the need to understand more fully the role of emotion in the development of central nervous system disorders and the role that emotion plays in the decision-making process.
Journal ArticleDOI
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
Felice Gragnano,Marcel Zwahlen,Pascal Vranckx,Dik Heg,Kurt Schmidlin,Christian W. Hamm,Philippe Gabriel Steg,Giuseppe Gargiulo,Eugene P. McFadden,Yoshinobu Onuma,Ply Chichareon,Edouard Benit,Helge Möllmann,Luc Janssens,Sergio Leonardi,Aleksander Zurakowski,Alessio Arrivi,Robert-Jan van Geuns,Kurt Huber,Ton Slagboom,Paolo Calabrò,Patrick W. Serruys,Peter Jüni,Marco Valgimigli,Stephan Windecker +24 more
TL;DR: Among patients who complied with the study protocol in the GLOBAL LEADERS trial, ticagrelor plus aspirin for 1 month followed by ticgrelor monotherapy was not superior to 1‐year standard dual antiplatelet therapy followed by aspirin alone at 2 years after coronary stenting.